Invention Grant
- Patent Title: Pneumoccal polysacchride conjugate vaccine
-
Application No.: US14729408Application Date: 2015-06-03
-
Publication No.: US09884113B2Publication Date: 2018-02-06
- Inventor: Ralph Leon Biemans , Nathalie Marie-Josephe Garcon , Philippe Vincent Hermand , Jan Poolman , Marcelle Paulette Van Mechelen
- Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals, SA
- Current Assignee: GlaxoSmithKline Biologicals, SA
- Current Assignee Address: BE Rixensart
- Agent Barbara J. Carter
- Priority: GB0526232.4 20051222; GB0607087.4 20060407; GB0607088.2 20060407; GB0609902.2 20060518; GB0620336.8 20061012; GB0620337.6 20061012; GB0620815.1 20061019; GB0620816.9 20061019; WOPCT/GB2006/004634 20061212
- Main IPC: A61K39/09
- IPC: A61K39/09 ; A61K39/00 ; A61K39/385 ; A61K47/64
Abstract:
The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, a multivalent Streptococcus pneumoniae immunogenic composition is provided with various conjugated capsular saccharides from different S. pneumoniae serotypes conjugated to 2 or more different carrier proteins, where the composition comprises serotype 19F capsular saccharide conjugated to diphtheria toxoid (DT) or CRM197, optionally wherein 19F is the only saccharide in the composition conjugated to diphtheria toxoid (DT) or CRM197.
Public/Granted literature
- US20150265702A1 PNEUMOCCAL POLYSACCHRIDE CONJUGATE VACCINE Public/Granted day:2015-09-24
Information query
